To soften the blow, CSPC has accelerated its shift from generic drugs to innovative medicines. In the first three quarters, the company's spending on R&D rose 7.9% to 4.19 billion yuan, equivalent to ...

China’s growing capabilities have drawn pharmaceutical multinationals to the country to either buy or co-develop innovative ...

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow, characterized by rapid growth of abnormal white blood cells. As AML primarily affects older adults, the global rise ...

With big moves and investments being made via pharma outsourcing, it’s important for industry professionals to stay on top of trends and innovations.

Just 10 years ago, there was virtually no biopharmaceutical industry in China. But now, almost all global big pharma ...

Frederick, MD — Gov. Wes Moore on Friday announced that AstraZeneca will invest $2 billion to expand its operations in Maryland in what he described as the “single largest private investment in ...

DEVELOPMENTS FROM FREDERICK. THE INVESTMENT PROVIDES AN ECONOMIC SHOT IN THE ARM, CREATES JOBS AND BOOSTS THE STATE’S EFFORT TO EXPAND MARYLAND’S LIFE SCIENCES SECTOR. TODAY IS ABOUT SHOWING THAT WE ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its ...

Wondering if AstraZeneca’s impressive reputation matches up with its current share price? Let’s take a closer look at what might make it attractive for value-minded investors. The stock has seen a ...

DelveInsight’s “Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 250+ Breast Cancer ...